Prime Medicine Statistics
Share Statistics
Prime Medicine has 131.29M
shares outstanding. The number of shares has increased by 9.27%
in one year.
Shares Outstanding | 131.29M |
Shares Change (YoY) | 9.27% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 52.96% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 1,505 |
FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 17.7M, so 13.48% of the outstanding
shares have been sold short.
Short Interest | 17.7M |
Short % of Shares Out | 13.48% |
Short % of Float | 26.11% |
Short Ratio (days to cover) | 12.73 |
Valuation Ratios
The PE ratio is -1.77 and the forward
PE ratio is -1.18.
Prime Medicine's PEG ratio is
0.07.
PE Ratio | -1.77 |
Forward PE | -1.18 |
PS Ratio | 116.1 |
Forward PS | 4.8 |
PB Ratio | 2.26 |
P/FCF Ratio | -2.66 |
PEG Ratio | 0.07 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Prime Medicine.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.58,
with a Debt / Equity ratio of 0.27.
Current Ratio | 5.58 |
Quick Ratio | 5.58 |
Debt / Equity | 0.27 |
Debt / EBITDA | -0.21 |
Debt / FCF | -0.31 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $13,939.25 |
Profits Per Employee | $-915,336.45 |
Employee Count | 214 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -81.83% in the
last 52 weeks. The beta is 1.9, so Prime Medicine's
price volatility has been higher than the market average.
Beta | 1.9 |
52-Week Price Change | -81.83% |
50-Day Moving Average | 1.49 |
200-Day Moving Average | 2.85 |
Relative Strength Index (RSI) | 41.34 |
Average Volume (20 Days) | 1,864,604 |
Income Statement
In the last 12 months, Prime Medicine had revenue of 2.98M
and earned -195.88M
in profits. Earnings per share was -1.65.
Revenue | 2.98M |
Gross Profit | -3.15M |
Operating Income | -202.47M |
Net Income | -195.88M |
EBITDA | -196.34M |
EBIT | -202.47M |
Earnings Per Share (EPS) | -1.65 |
Full Income Statement Balance Sheet
The company has 182.48M in cash and 40.79M in
debt, giving a net cash position of 141.68M.
Cash & Cash Equivalents | 182.48M |
Total Debt | 40.79M |
Net Cash | 141.68M |
Retained Earnings | -687.21M |
Total Assets | 328.16M |
Working Capital | 129.48M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -122.86M
and capital expenditures -7.29M, giving a free cash flow of -130.16M.
Operating Cash Flow | -122.86M |
Capital Expenditures | -7.29M |
Free Cash Flow | -130.16M |
FCF Per Share | -1.1 |
Full Cash Flow Statement Margins
Gross margin is -105.43%, with operating and profit margins of -6787.36% and -6566.61%.
Gross Margin | -105.43% |
Operating Margin | -6787.36% |
Pretax Margin | -6566.61% |
Profit Margin | -6566.61% |
EBITDA Margin | -6581.93% |
EBIT Margin | -6787.36% |
FCF Margin | -4363.36% |